The history of Viagra presents a nuanced case for investors in the medicinal sector. While initially a phenomenal success, creating billions, the exclusivity end and the subsequent entry of generic versions have considerably affected revenue. This raises questions about the long-term viability of related therapeutic developments and suggests tha… Read More